Financial Toxicity in American Patients Receiving Cancer Immunotherapy Drugs

Researched by Belong.Life and published by ASCO
Key Findings: Financial toxicity is most prevalent in American patients older than 61. Half of those patients were unaware of possible issues of financial toxicity and only 29.3% received pre-treatment FT advice from their doctors. Those who did receive advice saw a 41% reduction in financial toxicity incidence.


To the research>

דילוג לתוכן